Yadira Torres MAS/LinkedIn
Sep 15, 2026, 11:55
Yadira Torres MAS: Predicting Chronic Immune Thrombocytopenia in Children
Yadira Torres MAS, Executive Director at Children’s Hospital Los Angeles, shared CHLA’s post on LinkedIn:
“A new study led by CHLA may help answer a key question for physicians treating children with immune thrombocytopenia (ITP):
Which patients will recover on their own, and which will develop chronic disease?”
Children’s Hospital Los Angeles (CHLA) shared a post on LinkedIn:
“Which children with immune thrombocytopenia (ITP) will recover on their own and which will develop chronic disease?
A multicenter study led by CHLA’s Dr. Taylor Kim validated a prediction model that could help physicians answer that question when a child is first diagnosed.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 11:44Chokri Ben Lamine: Matching Anemia Treatment to the Myelofibrosis Patient
-
Sep 15, 2026, 11:17Adam Urato: How SSRIs May Affect Maternal and Fetal Serotonin
-
Sep 15, 2026, 11:05Sudhir Kumar: Maternal Anemia May Shape a Child’s Brain Development
-
Sep 15, 2026, 10:48Ashok Singhal: A Life-Changing Transplant Brings New Hope for Beta Thalassemia
-
Sep 15, 2026, 10:33Vera Ghali: Mitapivat Opens a New Chapter in Thalassemia Treatment
-
Sep 15, 2026, 10:13Behnood Bikdeli: Exploring the Role of Antiphospholipid Antibodies in Ischemic Stroke
-
Sep 15, 2026, 09:55Mark Mamlouk: When Postpartum Headache Signals More Than a CSF Leak
-
Sep 15, 2026, 09:46Nicholas Raccagni: Heparin for VTE Prevention After Traumatic Brain Injury
-
Sep 15, 2026, 09:34Mario D. Caldararo: Are Lines of Zahn Pathognomonic for Antemortem Thrombosis?